Comparative analysis between ziprasidone and risperidone in treatment of schizophrenia
Chen Ke-qua
Abstract
Chen Ke-qua
Abstract
Objective:To explore the efficacy and safety of ziprasidone in treatment of schizophrenia.Method:80 patients with schizophrenia were randomly assigned to two groups,ziprasidone group(n=40)and resperidone group(n=40)for 8 weeks.Positive and negative syndrome scale(PANSS)and treatment emergent side effect scale(TESS)were used to evaluate the efficacy and side effects respectively.Results:The response rate and marked response rate in patients of ziprasidone group were 65.0% and 85.0% after 8 weeks,similar to risperidone group.Both the total PANSS scores and factor scores decreased significantly after treatment in two groups(67.5% and 87.5%).However,there were no significant differences between two groups.Total incidence of side effects in ziprasidone group was significantly lower than that in risperidone group.Conclusion:Ziprasidone has a better efficacy in treatment of schizophrenia,which is as effective as resperidone and has fewer side effects compared with risperidone.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To explore the efficacy and safety of ziprasidone in treatment of schizophrenia.Method:80 patients with schizophrenia were randomly assigned to two groups,ziprasidone group(n=40)and resperidone group(n=40)for 8 weeks.Positive and negative syndrome scale(PANSS)and treatment emergent side effect scale(TESS)were used to evaluate the efficacy and side effects respectively.Results:The response rate and marked response rate in patients of ziprasidone group were 65.0% and 85.0% after 8 weeks,similar to risperidone group.Both the total PANSS scores and factor scores decreased significantly after treatment in two groups(67.5% and 87.5%).However,there were no significant differences between two groups.Total incidence of side effects in ziprasidone group was significantly lower than that in risperidone group.Conclusion:Ziprasidone has a better efficacy in treatment of schizophrenia,which is as effective as resperidone and has fewer side effects compared with risperidone.
Key concepts: Ziprasidone, Risperidone, Positive and Negative Syndrome Scale, Schizophrenia (object-oriented programming), Internal medicine, Psychology, Side effect (computer science), Negative symptom